Alpha 7 nicotinic acetylcholine receptors: Molecular pharmacology and role in neuroprotection

Current Anaesthesia and Critical Care

Volumn 19, Issue 4, 2008, Pages 202-214

  van Rensburg, Ruan ^a   Chazot, Paul L ^a  

^a DURHAM UNIVERSITY   (United Kingdom)

Author keywords

Neuroprotection; Nicotine; Nicotinic receptors; Ric 3; Subtypes

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; ALPHA BUNGAROTOXIN; ALPHA4BETA2 NICOTINIC RECEPTOR; ANABASINE; BUNGAROTOXIN RECEPTOR; DIHYDRO BETA ERYTHROIDINE; EPIBATIDINE; METHYLLYCACONITINE; NICOTINE; NICOTINIC RECEPTOR; OLIGOMER; PROTEIN RIC 3;

ALZHEIMER DISEASE; ANXIETY DISORDER; ARTICLE; BINDING AFFINITY; CELL SURFACE; CELL SURVIVAL; DRUG POTENCY; EPILEPSY; HUMAN; LEARNING; MEMORY; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN TARGETING; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION;

EID: 48749107685     PISSN: 09537112     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cacc.2008.05.001     Document Type: Article

References (145)

1. Zhao H., Tuominen E.K., and Kinnunen P.K. Formation of amyloid fibers triggered by phosphatidylserine-containing membranes. Biochemistry 43 32 (2004) 10302-10307
2. Patrick J., Boulter J., Goldman D., Gardner P., and Heinemann S. Molecular biology of nicotinic acetylcholine receptors. Ann N Y Acad Sci 505 (1987) 194-207
3. 2+. Neuron 8 2 (1992) 353-362
4. Alkondon M., and Albuquerque E.X. The nicotinic acetylcholine receptor subtypes and their function in the hippocampus and cerebral cortex. Prog Brain Res 145 (2004) 109-120
5. Lukas R.J., Changeux J.P., Le Novère N., Albuquerque E.X., Balfour D.J., Berg D.K., et al. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev 51 2 (1999) 397-401
6. Cooper E., Couturier S., and Ballivet M. Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor. Nature 350 6315 (1991) 235-238
7. Galzi J.L., Revah F., Bessis A., and Changeux J.P. Functional architecture of the nicotinic acetylcholine receptor: from electric organ to brain. Annu Rev Pharmacol Toxicol 31 (1991) 37-72
8. Lukas R.J., and Bencherif M. Heterogeneity and regulation of nicotinic acetylcholine receptors. Int Rev Neurobiol 34 (1992) 25-131
9. Salvaterra P.M., and Moore W.J. Binding of (125I)-alpha bungarotoxin to particulate fractions of rat and guinea pig brain. Biochem Biophys Res Commun 55 4 (1973) 1311-1318
10. Eterović V.A., and Bennett E.L. Nicotinic cholinergic receptor in brain detected by binding of alpha-(3H) bungarotoxin. Biochim Biophys Acta 362 2 (1974) 346-355
11. McQuarrie C., Salvaterra P.M., De Blas A., Routes J., and Mahler H.R. Studies on nicotinic acetylcholine receptors in mammalian brain. Preliminary characterization of membrane-bound alpha-bungarotoxin receptors in rat cerebral cortex. J Biol Chem 251 20 (1976) 6335-6339
12. Oswald R.E., and Freeman J.A. Alpha-bungarotoxin binding and central nervous system nicotinic acetylcholine receptors. Neuroscience 6 1 (1981) 1-14
13. Elgoyhen A.B., Vetter D.E., Katz E., Rothlin C.V., Heinemann S.F., and Boulter J. alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proc Natl Acad Sci USA 98 6 (2001) 3501-3506
14. Marks M.J., Stitzel J.A., Romm E., Wehner J.M., and Collins A.C. Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin. Mol Pharmacol 30 5 (1986) 427-436
15. Wonnacott S. alpha-Bungarotoxin binds to low-affinity nicotine binding sites in rat brain. J Neurochem 47 6 (1986) 1706-1712
16. Goldman D., Deneris E., Luyten W., Kochhar A., Patrick J., and Heinemann S. Members of a nicotinic acetylcholine receptor gene family are expressed in different regions of the mammalian central nervous system. Cell 48 6 (1987) 965-973
17. Schoepfer R., Conroy W.G., Whiting P., Gore M., and Lindstrom J. Brain alpha-bungarotoxin binding protein cDNAs and MAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily. Neuron 5 1 (1990) 35-48
18. Amar M., Thomas P., Johnson C., Lunt G.G., and Wonnacott S. Agonist pharmacology of the neuronal alpha7 nicotinic receptor expressed in Xenopus oocytes. FEBS Lett 327 3 (1993) 284-288
19. Zhang Z.W., Vijayaraghavan S., and Berg D.K. Neuronal acetylcholine receptors that bind alpha-bungarotoxin with high affinity function as ligand-gated ion channels. Neuron 12 1 (1994) 167-177
20. Palma E., Maggi L., Barabino B., Eusebi F., and Ballivet M. Nicotinic acetylcholine receptors assembled from the alpha7 and beta3 subunits. J Biol Chem 274 26 (1999) 18335-18340
21. Khiroug S.S., Harkness P.C., Lamb P.W., Sudweeks S.N., Khiroug L., Millar N.S., et al. Rat nicotinic ACh receptor alpha7 and beta2 subunits co-assemble to form functional heteromeric nicotinic receptor channels. J Physiol 540 Part 2 (2002) 425-434
22. 125I]-alpha-bungarotoxin. J Neurosci 5 5 (1985) 1307-1315
23. Gault J., Robinson M., Berger R., Drebing C., Logel J., Hopkins J., et al. Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics 52 2 (1998) 173-185
24. Belluardo N., Mudò G., Blum M., and Fuxe K. Central nicotinic receptors, neurotrophic factors and neuroprotection. Behav Brain Res 113 1-2 (2000) 21-34
25. Elgoyhen A.B., Johnson D.S., Boulter J., Vetter D.E., and Heinemann S. Alpha9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 79 4 (1994) 705-715
26. Lustig L.R., Peng H., Hiel H., Yamamoto T., and Fuchs P.A. Molecular cloning and mapping of the human nicotinic acetylcholine receptor alpha10 (CHRNA10). Genomics 73 3 (2001) 272-283
27. Rubboli F., Court J.A., Sala C., Morris C., Perry E., and Clementi F. Distribution of neuronal nicotinic receptor subunits in human brain. Neurochem Int 25 1 (1994) 69-71
28. 125I]-alpha-bungarotoxin binding in human postmortem brain. J Comp Neurol 387 3 (1997) 385-398
29. 125I] alpha-bungarotoxin binding. J Chem Neuroanat 13 2 (1997) 105-113
30. Paterson D., and Nordberg A. Neuronal nicotinic receptors in the human brain. Prog Neurobiol 61 1 (2000) 75-111
31. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci 20 2 (1997) 92-98
32. Sher E., Chen Y., Sharples T.J., Broad L.M., Benedetti G., Zwart R., et al. Physiological roles of neuronal nicotinic receptor subtypes: new insights on the nicotinic modulation of neurotransmitter release, synaptic transmission and plasticity. Curr Top Med Chem 4 3 (2004) 283-297
33. Jensen A.A., Frølund B., Liljefors T., and Krogsgaard-Larsen P. Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J Med Chem 48 15 (2005) 4705-4745
34. Choi D.W., Maulucci-Gedde M., and Kriegstein A.R. Glutamate neurotoxicity in cortical cell culture. J Neurosci 7 2 (1987) 357-368
35. Séguéla P., Wadiche J., Dineley-Miller K., Dani J.A., and Patrick J.W. Molecular cloning, functional properties, and distribution of rat brain alpha7: a nicotinic cation channel highly permeable to calcium. J Neurosci 13 2 (1993) 596-604
36. Rothman S.M., and Olney J.W. Excitotoxicity and the NMDA receptor-still lethal after eight years. Trends Neurosci 18 2 (1995) 57-58
37. Treinin M., and Chalfie M. A mutated acetylcholine receptor subunit causes neuronal degeneration in C. elegans. Neuron 14 4 (1995) 871-877
38. Donnelly-Roberts D.L., Xue I.C., Arneric S.P., and Sullivan J.P. In vitro neuroprotective properties of the novel cholinergic channel activator (ChCA), ABT-418. Brain Res 719 1-2 (1996) 36-44
39. Gotti C., and Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol 74 6 (2004) 363-396
40. Kem W.R. The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21). Behav Brain Res 113 1-2 (2000) 169-181
41. Picciotto M.R., Caldarone B.J., Brunzell D.H., Zachariou V., Stevens T.R., and King S.L. Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications. Pharmacol Ther 92 2-3 (2001) 89-108
42. Martin L.F., and Freedman R. Schizophrenia and the alpha7 Nicotinic Acetylcholine Receptor. Int Rev Neurobiol 78 (2007) 225-246
43. Morissette S.B., Tull M.T., Gulliver S.B., Kamholz B.W., and Zimering R.T. Anxiety, anxiety disorders, tobacco use, and nicotine: a critical review of interrelationships. Psychol Bull 133 2 (2007) 245-272
44. Orr-Urtreger A., Göldner F.M., Saeki M., Lorenzo I., Goldberg L., De Biasi M., et al. Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. J Neurosci 17 23 (1997) 9165-9171
45. Orr-Urtreger A., Broide R.S., Kasten M.R., Dang H., Dani J.A., Beaudet A.L., et al. Mice homozygous for the L250T mutation in the alpha7 nicotinic acetylcholine receptor show increased neuronal apoptosis and die within 1 day of birth. J Neurochem 74 5 (2000) 2154-2166
46. Peng X., Katz M., Gerzanich V., Anand R., and Lindstrom J. Human alpha7 acetylcholine receptor: cloning of the alpha7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha7 homomers expressed in Xenopus oocytes. Mol Pharmacol 45 3 (1994) 546-554
47. Matter-Sadzinski L., Hernandez M.C., Roztocil T., Ballivet M., and Matter J.M. Neuronal specificity of the alpha7 nicotinic acetylcholine receptor promoter develops during morphogenesis of the central nervous system. EMBO J 11 12 (1992) 4529-4538
48. García-Guzmán M., Sala F., Sala S., Campos-Caro A., Stühmer W., Gutiérrez L.M., et al. alpha-Bungarotoxin-sensitive nicotinic receptors on bovine chromaffin cells: molecular cloning, functional expression and alternative splicing of the alpha7 subunit. Eur J Neurosci 7 4 (1995) 647-655
49. Jones I.W., and Wonnacott S. Why doesn't nicotinic ACh receptor immunoreactivity knock out?. Trends Neurosci 28 7 (2005) 343-345
50. Moser N., Mechawar N., Jones I., Gochberg-Sarver A., Orr-Urtreger A., Plomann M., et al. Evaluating the suitability of nicotinic acetylcholine receptor antibodies for standard immunodetection procedures. J Neurochem 102 2 (2007) 479-492
51. Herber D.L., Severance E.G., Cuevas J., Morgan D., and Gordon M.N. Biochemical and histochemical evidence of nonspecific binding of alpha7 nAChR antibodies to mouse brain tissue. J Histochem Cytochem 52 10 (2004) 1367-1376
52. Nagavarapu U., Danthi S., and Boyd R.T. Characterization of a rat neuronal nicotinic acetylcholine receptor alpha7 promoter. J Biol Chem 276 20 (2001) 16749-16757
53. Boisclair Y.R., Brown A.L., Casola S., and Rechler M.M. Three clustered Sp1 sites are required for efficient transcription of the TATA-less promoter of the gene for insulin-like growth factor-binding protein-2 from the rat. J Biol Chem 268 33 (1993) 24892-24901
54. Ebert S.N., and Wong D.L. Differential activation of the rat phenylethanolamine N-methyltransferase gene by Sp1 and Egr-1. J Biol Chem 270 29 (1995) 17299-17305
55. Carrasco-Serrano C., Campos-Caro A., Viniegra S., Ballesta J.J., and Criado M. GC- and E-box motifs as regulatory elements in the proximal promoter region of the neuronal nicotinic receptor alpha7 subunit gene. J Biol Chem 273 32 (1998) 20021-20028
56. Carrasco-Serrano C., Viniegra S., Ballesta J.J., and Criado M. Phorbol ester activation of the neuronal nicotinic acetylcholine receptor alpha7 subunit gene: involvement of transcription factor Egr-1. J Neurochem 74 3 (2000) 932-939
57. Carrasco-Serrano C., and Criado M. Glucocorticoid activation of the neuronal nicotinic acetylcholine receptor alpha7 subunit gene: involvement of transcription factor Egr-1. FEBS Lett 566 1-3 (2004) 247-250
58. Tsai-Morris C.H., Cao X.M., and Sukhatme V.P. 5' flanking sequence and genomic structure of Egr-1, a murine mitogen inducible zinc finger encoding gene. Nucleic Acids Res 16 18 (1988) 8835-8846
59. Cao X., Mahendran R., Guy G.R., and Tan Y.H. Detection and characterization of cellular EGR-1 binding to its recognition site. J Biol Chem 268 23 (1993) 16949-16957
60. Sukhatme V.P., Cao X.M., Chang L.C., Tsai-Morris C.H., Stamenkovich D., Ferreira P.C., et al. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 53 1 (1988) 37-43
61. Enslen H., and Soderling T.R. Roles of calmodulin-dependent protein kinases and phosphatase in calcium-dependent transcription of immediate early genes. J Biol Chem 269 33 (1994) 20872-20877
62. Abe K., Kawagoe J., Sato S., Sahara M., and Kogure K. Induction of the 'zinc finger' gene after transient focal ischemia in rat cerebral cortex. Neurosci Lett 123 2 (1991) 248-250
63. Herdegen T., Kiessling M., Bele S., Bravo R., Zimmermann M., and Gass P. The KROX-20 transcription factor in the rat central and peripheral nervous systems: novel expression pattern of an immediate early gene-encoded protein. Neuroscience 57 1 (1993) 41-52
64. Utsugisawa K., Nagane Y., Tohgi H., Yoshimura M., Ohba H., and Genda Y. Changes with aging and ischemia in nicotinic acetylcholine receptor subunit alpha7 mRNA expression in postmortem human frontal cortex and putamen. Neurosci Lett 270 3 (1999) 145-148
65. Bessis A., Savatier N., Devillers-Thiéry A., Bejanin S., and Changeux J.P. Negative regulatory elements upstream of a novel exon of the neuronal nicotinic acetylcholine receptor alpha2 subunit gene. Nucleic Acids Res 21 9 (1993) 2185-2192
66. Milton N.G., Bessis A., Changeux J.P., and Latchman D.S. The neuronal nicotinic acetylcholine receptor alpha2 subunit gene promoter is activated by the Brn-3b POU family transcription factor and not by Brn-3a or Brn-3c. J Biol Chem 270 25 (1995) 15143-15147
67. Yang X., Fyodorov D., and Deneris E.S. Transcriptional analysis of acetylcholine receptor alpha3 gene promoter motifs that bind Sp1 and AP2. J Biol Chem 270 15 (1995) 8514-8520
68. Liu Q., Melnikova I.N., Hu M., and Gardner P.D. Cell type-specific activation of neuronal nicotinic acetylcholine receptor subunit genes by Sox10. J Neurosci 19 22 (1999) 9747-9755
69. Du Q., Melnikova I.N., and Gardner P.D. Differential effects of heterogeneous nuclear ribonucleoprotein K on Sp1- and Sp3-mediated transcriptional activation of a neuronal nicotinic acetylcholine receptor promoter. J Biol Chem 273 31 (1998) 19877-19883
70. Campos-Caro A., Carrasco-Serrano C., Valor L.M., Ballesta J.J., and Criado M. Activity of the nicotinic acetylcholine receptor alpha5 and alpha7 subunit promoters in muscle cells. DNA Cell Biol 20 10 (2001) 657-666
71. Ebihara M., Ohba H., Ohno S.I., and Yoshikawa T. Genomic organization and promoter analysis of the human nicotinic acetylcholine receptor alpha6 subunit (CHNRA6) gene: Alu and other elements direct transcriptional repression. Gene 298 1 (2002) 101-108
72. Valor L.M., Castillo M., Ortiz J.A., and Criado M. Transcriptional regulation by activation and repression elements located at the 5'-noncoding region of the human alpha9 nicotinic receptor subunit gene. J Biol Chem 278 39 (2003) 37249-37255
73. Lustig L.R., and Peng H. Chromosome location and characterization of the human nicotinic acetylcholine receptor subunit alpha (alpha) 9 (CHRNA9) gene. Cytogenet Genome Res 98 2-3 (2002) 154-159
74. Poser S., Impey S., Xia Z., and Storm D.R. Brain-derived neurotrophic factor protection of cortical neurons from serum withdrawal-induced apoptosis is inhibited by cAMP. J Neurosci 23 11 (2003) 4420-4427
75. Avramopoulou V., Mamalaki A., and Tzartos S.J. Soluble, oligomeric, and ligand-binding extracellular domain of the human alpha7 acetylcholine receptor expressed in yeast: replacement of the hydrophobic cysteine loop by the hydrophilic loop of the ACh-binding protein enhances protein solubility. J Biol Chem 279 37 (2004) 38287-38293
76. Arias H.R. Topology of ligand binding sites on the nicotinic acetylcholine receptor. Brain Res Brain Res Rev 25 2 (1997) 133-191
77. Brejc K., van Dijk W.J., Klaassen R.V., Schuurmans M., van Der Oost J., Smit A.B., et al. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 411 6835 (2001) 269-276
78. Celie P.H., van Rossum-Fikkert S.E., van Dijk W.J., Brejc K., Smit A.B., and Sixma T.K. Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures. Neuron 41 6 (2004) 907-914
79. Celie P.H., Kasheverov I.E., Mordvintsev D.Y., Hogg R.C., van Nierop P., van Elk R., et al. Crystal structure of nicotinic acetylcholine receptor homolog AChBP in complex with an alpha-conotoxin PnIA variant. Nat Struct Mol Biol 12 7 (2005) 582-588
80. Smit A.B., Syed N.I., Schaap D., van Minnen J., Klumperman J., Kits K.S., et al. A glia-derived acetylcholine-binding protein that modulates synaptic transmission. Nature 411 6835 (2001) 261-268
81. Smit A.B., Brejc K., Syed N., and Sixma T.K. Structure and function of AChBP, homologue of the ligand-binding domain of the nicotinic acetylcholine receptor. Ann N Y Acad Sci 998 (2003) 81-92
82. Marinou M., and Tzartos S.J. Identification of regions involved in the binding of alpha-bungarotoxin to the human alpha7 neuronal nicotinic acetylcholine receptor using synthetic peptides. Biochem J 372 Part 2 (2003) 543-554
83. Kemp B.E., and Pearson R.B. Protein kinase recognition sequence motifs. Trends Biochem Sci 15 9 (1990) 342-346
84. Unwin N., Toyoshima C., and Kubalek E. Arrangement of the acetylcholine receptor subunits in the resting and desensitized states, determined by cryoelectron microscopy of crystallized Torpedo postsynaptic membranes. J Cell Biol 107 3 (1988) 1123-1138
85. Unwin N. Nicotinic acetylcholine receptor at 9 Å resolution. J Mol Biol 229 4 (1993) 1101-1124
86. Unwin N. Acetylcholine receptor channel imaged in the open state. Nature 373 6509 (1995) 37-43
87. Unwin N. Projection structure of the nicotinic acetylcholine receptor: distinct conformations of the alpha subunits. J Mol Biol 257 3 (1996) 586-596
88. Bertrand D., Galzi J.L., Devillers-Thiéry A., Bertrand S., and Changeux J.P. Stratification of the channel domain in neurotransmitter receptors. Curr Opin Cell Biol 5 4 (1993) 688-693
89. Karlin A. Structure of nicotinic acetylcholine receptors. Curr Opin Neurobiol 3 3 (1993) 299-309
90. Ortells M.O., and Lunt G.G. A mixed helix-beta-sheet model of the transmembrane region of the nicotinic acetylcholine receptor. Protein Eng 9 1 (1996) 51-59
91. Görne-Tschelnokow U., Strecker A., Kaduk C., Naumann D., and Hucho F. The transmembrane domains of the nicotinic acetylcholine receptor contain alpha-helical and beta structures. EMBO J 13 2 (1994) 338-341
92. Halevi S., McKay J., Palfreyman M., Yassin L., Eshel M., Jorgensen E., et al. The C. elegans ric-3 gene is required for maturation of nicotinic acetylcholine receptors. EMBO J 21 5 (2002) 1012-1020
93. Treinin M., Gillo B., Liebman L., and Chalfie M. Two functionally dependent acetylcholine subunits are encoded in a single Caenorhabditis elegans operon. Proc Natl Acad Sci USA 95 26 (1998) 15492-15495
94. Dominguez del Toro E., Juiz J.M., Peng X., Lindstrom J., and Criado M. Immunocytochemical localization of the alpha7 subunit of the nicotinic acetylcholine receptor in the rat central nervous system. J Comp Neurol 349 3 (1994) 325-342
95. Keller S.H., Lindstrom J., Ellisman M., and Taylor P. Adjacent basic amino acid residues recognized by the COP I complex and ubiquitination govern endoplasmic reticulum to cell surface trafficking of the nicotinic acetylcholine receptor alpha-subunit. J Biol Chem 276 21 (2001) 18384-18391
96. Lansdell S.J., Gee V.J., Harkness P.C., Doward A.I., Baker E.R., Gibb A.J., et al. RIC-3 enhances functional expression of multiple nicotinic acetylcholine receptor subtypes in mammalian cells. Mol Pharmacol 68 5 (2005) 1431-1438
97. Williams M.E., Burton B., Urrutia A., Shcherbatko A., Chavez-Noriega L.E., Cohen C.J., et al. Ric-3 promotes functional expression of the nicotinic acetylcholine receptor alpha7 subunit in mammalian cells. J Biol Chem 280 2 (2005) 1257-1263
98. Cooper S.T., and Millar N.S. Host cell-specific folding and assembly of the neuronal nicotinic acetylcholine receptor alpha7 subunit. J Neurochem 68 5 (1997) 2140-2151
99. Sweileh W., Wenberg K., Xu J., Forsayeth J., Hardy S., and Loring R.H. Multistep expression and assembly of neuronal nicotinic receptors is both host-cell- and receptor-subtype-dependent. Brain Res Mol Brain Res 75 2 (2000) 293-302
100. Halevi S., Yassin L., Eshel M., Sala F., Sala S., Criado M., et al. Conservation within the RIC-3 gene family. Effectors of mammalian nicotinic acetylcholine receptor expression. J Biol Chem 278 36 (2003) 34411-34417
101. Blount P., and Merlie J.P. BIP associates with newly synthesized subunits of the mouse muscle nicotinic receptor. J Cell Biol 113 5 (1991) 1125-1132
102. Chang W., Gelman M.S., and Prives J.M. Calnexin-dependent enhancement of nicotinic acetylcholine receptor assembly and surface expression. J Biol Chem 272 46 (1997) 28925-28932
103. Jeanclos E.M., Lin L., Treuil M.W., Rao J., DeCoster M.A., and Anand R. The chaperone protein 14-3-3eta interacts with the nicotinic acetylcholine receptor alpha4 subunit. Evidence for a dynamic role in subunit stabilization. J Biol Chem 276 30 (2001) 28281-28290
104. Alexander JK, Jefford G, Criado M, Sagher D, Green WN. Ric-3 levels in the ER determine whether alpha-7 nicotinic receptors are expressed at the surface or retained in the ER. Society for Neuroscience Poster, 2007; 575.3/K3.
105. Cheng A., McDonald N.A., and Connolly C.N. Cell surface expression of 5-hydroxytryptamine type 3 receptors is promoted by RIC-3. J Biol Chem 280 23 (2005) 22502-22507
106. 3H]nicotine binding sites in human brain. J Neurochem 50 4 (1988) 1243-1247
107. Nybäck H., Nordberg A., Långström B., Halldin C., Hartvig P., Ahlin A., et al. Attempts to visualize nicotinic receptors in the brain of monkey and man by positron emission tomography. Prog Brain Res 79 (1989) 313-319
108. Romanelli L., Ohman B., Adem A., and Nordberg A. Subchronic treatment of rats with nicotine: interconversion of nicotinic receptor subtypes in brain. Eur J Pharmacol 148 2 (1988) 289-291
109. Wonnacott S. The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol Sci 11 6 (1990) 216-219
110. Flores C.M., Rogers S.W., Pabreza L.A., Wolfe B.B., and Kellar K.J. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha4 and beta2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol 41 1 (1992) 31-37
111. Barrantes G.E., Rogers A.T., Lindstrom J., and Wonnacott S. alpha-Bungarotoxin binding sites in rat hippocampal and cortical cultures: initial characterisation, colocalisation with alpha7 subunits and up-regulation by chronic nicotine treatment. Brain Res 672 1-2 (1995) 228-236
112. Rowell P.P., and Li M. Dose-response relationship for nicotine-induced up-regulation of rat brain nicotinic receptors. J Neurochem 68 5 (1997) 1982-1989
113. Gopalakrishnan M., Molinari E.J., and Sullivan J.P. Regulation of human alpha4 beta2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways. Mol Pharmacol 52 3 (1997) 524-534
114. Zoli M., Léna C., Picciotto M.R., and Changeux J.P. Identification of four classes of brain nicotinic receptors using beta2 mutant mice. J Neurosci 18 12 (1998) 4461-4472
115. Pauly J.R., Marks M.J., Gross S.D., and Collins A.C. An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment. J Pharmacol Exp Ther 258 3 (1991) 1127-1136
116. Peng X., Gerzanich V., Anand R., Wang F., and Lindstrom J. Chronic nicotine treatment up-regulates alpha3 and alpha7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y. Mol Pharmacol 51 5 (1997) 776-784
117. Quik M., Choremis J., Komourian J., Lukas R.J., and Puchacz E. Similarity between rat brain nicotinic alpha-bungarotoxin receptors and stably expressed alpha-bungarotoxin binding sites. J Neurochem 67 1 (1996) 145-154
118. Molinari E.J., Delbono O., Messi M.L., Renganathan M., Arneric S.P., Sullivan J.P., et al. Up-regulation of human alpha7 nicotinic receptors by chronic treatment with activator and antagonist ligands. Eur J Pharmacol 347 1 (1998) 131-139
119. 3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs. J Neurochem 45 2 (1985) 427-433
120. Olale F., Gerzanich V., Kuryatov A., Wang F., and Lindstrom J. Chronic nicotine exposure differentially affects the function of human alpha3, alpha4, and alpha7 neuronal nicotinic receptor subtypes. J Pharmacol Exp Ther 283 2 (1997) 675-683
121. Reitstetter R., Lukas R.J., and Gruener R. Dependence of nicotinic acetylcholine receptor recovery from desensitization on the duration of agonist exposure. J Pharmacol Exp Ther 289 2 (1999) 656-660
122. Rowell P.P., and Duggan D.S. Long-lasting inactivation of nicotinic receptor function in vitro by treatment with high concentrations of nicotine. Neuropharmacology 37 1 (1998) 103-111
123. Marks M.J., Pauly J.R., Gross S.D., Deneris E.S., Hermans-Borgmeyer I., Heinemann S.F., et al. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci 12 7 (1992) 2765-2784
124. Bencherif M., Fowler K., Lukas R.J., and Lippiello P.M. Mechanisms of up-regulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain. J Pharmacol Exp Ther 275 2 (1995) 987-994
125. Zhang X., Gong Z.H., Hellström-Lindahl E., and Nordberg A. Regulation of alpha4 beta2 nicotinic acetylcholine receptors in M10 cells following treatment with nicotinic agents. Neuroreport 6 2 (1995) 313-317
126. Madhok T.C., Matta S.G., and Sharp B.M. Nicotine regulates nicotinic cholinergic receptors and subunit mRNAs in PC 12 cells through protein kinase A. Brain Res Mol Brain Res 32 1 (1995) 143-150
127. Hsu Y.N., Edwards S.C., and Wecker L. Nicotine enhances the cyclic AMP-dependent protein kinase-mediated phosphorylation of alpha4 subunits of neuronal nicotinic receptors. J Neurochem 69 6 (1997) 2427-2431
128. Eilers H., Schaeffer E., Bickler P.E., and Forsayeth J.R. Functional deactivation of the major neuronal nicotinic receptor caused by nicotine and a protein kinase C-dependent mechanism. Mol Pharmacol 52 6 (1997) 1105-1112
129. Chazot P.L., Godukhin O.V., McDonald A., and Obrenovitch T.P. Spreading depression-induced preconditioning in the mouse cortex: differential changes in the protein expression of ionotropic nicotinic acetylcholine and glutamate receptors. J Neurochem 83 5 (2002) 1235-1238
130. Tohgi H., Utsugisawa K., Yoshimura M., Nagane Y., and Mihara M. Alterations with aging and ischemia in nicotinic acetylcholine receptor subunits alpha4 and beta2 messenger RNA expression in postmortem human putamen. Implications for susceptibility to parkinsonism. Brain Res 791 1-2 (1998) 186-190
131. 2+/calmodulin-dependent kinase pathway. J Neurosci 15 12 (1995) 7966-7978
132. Ridley D.L., Rogers A., and Wonnacott S. Differential effects of chronic drug treatment on alpha3* and alpha7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cells. Br J Pharmacol 133 8 (2001) 1286-1295
133. Marin P., Maus M., Desagher S., Glowinski J., and Prémont J. Nicotine protects cultured striatal neurones against N-methyl-d-aspartate receptor-mediated neurotoxicity. Neuroreport 5 15 (1994) 1977-1980
134. Semba J., Miyoshi R., and Kito S. Nicotine protects against the dexamethasone potentiation of kainic acid-induced neurotoxicity in cultured hippocampal neurons. Brain Res 735 2 (1996) 335-338
135. Dajas-Bailador F.A., Lima P.A., and Wonnacott S. The alpha7 nicotinic acetylcholine receptor subtype mediates nicotine protection against NMDA excitotoxicity in primary hippocampal cultures through a Ca(2+) dependent mechanism. Neuropharmacology 39 13 (2000) 2799-2807
136. Tohgi H., Utsugisawa K., and Nagane Y. Protective effect of nicotine through nicotinic acetylcholine receptor alpha7 on hypoxia-induced membrane disintegration and DNA fragmentation of cultured PC12 cells. Neurosci Lett 285 2 (2000) 91-94
137. Hejmadi M.V., Dajas-Bailador F., Barns S.M., Jones B., and Wonnacott S. Neuroprotection by nicotine against hypoxia-induced apoptosis in cortical cultures involves activation of multiple nicotinic acetylcholine receptor subtypes. Mol Cell Neurosci 24 3 (2003) 779-786
138. Jonnala R.R., and Buccafusco J.J. Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists. J Neurosci Res 66 4 (2001) 565-572
139. Meyer E.M., Tay E.T., Zoltewicz J.A., Meyers C., King M.A., Papke R.L., et al. Neuroprotective and memory-related actions of novel alpha-7 nicotinic agents with different mixed agonist/antagonist properties. J Pharmacol Exp Ther 284 3 (1998) 1026-1032
140. Briggs C.A., and McKenna D.G. Activation and inhibition of the human alpha7 nicotinic acetylcholine receptor by agonists. Neuropharmacology 37 9 (1998) 1095-1102
141. Akaike A., Tamura Y., Yokota T., Shimohama S., and Kimura J. Nicotine-induced protection of cultured cortical neurons against N-methyl-d-aspartate receptor-mediated glutamate cytotoxicity. Brain Res 644 2 (1994) 181-187
142. Kaneko S., Maeda T., Kume T., Kochiyama H., Akaike A., Shimohama S., et al. Nicotine protects cultured cortical neurons against glutamate-induced cytotoxicity via alpha7-neuronal receptors and neuronal CNS receptors. Brain Res 765 1 (1997) 135-140
143. Maggio R., Riva M., Vaglini F., Fornai F., Molteni R., Armogida M., et al. Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors. J Neurochem 71 6 (1998) 2439-2446
144. O'Neill A.B., Morgan S.J., and Brioni J.D. Histological and behavioral protection by (-)-nicotine against quinolinic acid-induced neurodegeneration in the hippocampus. Neurobiol Learn Mem 69 1 (1998) 46-64
145. Borlongan C.V., Shytle R.D., Ross S.D., Shimizu T., Freeman T.B., Cahill D.W., et al. (-)-Nicotine protects against systemic kainic acid-induced excitotoxic effects. Exp Neurol 136 2 (1995) 261-265